A call for action: Managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings

Current Opinion in Infectious Diseases

Volumn 25, Issue 4, 2012, Pages 371-377

  Savard, Patrice ^a,b   Perl, Trish M ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

carbapenemase; Enterobacteriaceae; extended spectrum beta lactamase; infection prevention; multidrug resistance; review

Indexed keywords

BETA LACTAMASE; CARBAPENEMASE; CEFTRIAXONE; METALLO BETA LACTAMASE;

AEROMONAS PUNCTATA; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL TRANSMISSION; COST OF ILLNESS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; INFECTION PREVENTION; KINGELLA; KLEBSIELLA PNEUMONIAE; MORBIDITY; MORTALITY; MULTIDRUG RESISTANT ENTEROBACTERIACEAE; NOMENCLATURE; PRACTICE GUIDELINE; PSEUDOMONAS PSEUDOALCALIGENES; PSEUDOMONAS PUTIDA; PUBLIC HEALTH PROBLEM; REVIEW; SHIGELLA BOYDII; STENOTROPHOMONAS MALTOPHILIA; VIBRIO CHOLERAE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INFECTION CONTROL; INTENSIVE CARE; PREVALENCE;

EID: 84863671596     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3283558c17     Document Type: Review

References (39)

1. Patel G, Bonomo RA. Status report on carbapenemases: challenges and prospects. Expert Rev Anti Infect Ther 2011; 9:555-570.
2. Bilavsky E, Schwaber MJ, Carmeli Y. How to stem the tide of carbapenemaseproducing Enterobacteriaceae?: proactive versus reactive strategies. Curr Opin Infect Dis 2010; 23:327-331.
3. Kallen AJ, Hidron AI, Patel J, Srinivasan A. Multidrug resistance among Gramnegative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol 2010; 31:528-531.
4. Kallen AJ, Srinivasan A. Current epidemiology of multidrug-resistant Gramnegative bacilli in the United States. Infect Control Hosp Epidemiol 2010; 31 (Suppl 1):S51-S54.
5. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268-281.
6. Hombach M, Bloemberg GV, Bottger EC. Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli. J Antimicrob Chemother 2012; 67:622-632.
7. Bush K. Alarming beta-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol 2010; 13:558-564.
8. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011; 17:1791-1798.
9. Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol 2011; 19:588-595.
10. Walsh TR. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 2010; 36 (Suppl 3):S8-S14.
11. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011; 53:60-67.
12. Limbago BM, Rasheed JK, Anderson KF, et al. IMP-producing carbapenemresistant Klebsiella pneumoniae in the United States. J Clin Microbiol 2011; 49:4239-4245.
13. Centers for Disease Control and Prevention (CDC). Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase: United States, 2010. Morb Mortal Wkly Rep 59:750.
14. Centers for Disease Control and Prevention (CDC). Update: detection of a verona integron-encoded metallo-beta-lactamase in Klebsiella pneumoniae: United States, 2010. Morb Mortal Wkly Rep 59:1212.
15. Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-betalactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009; 53:5046-5054.
16. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10:597-602.
17. Castanheira M, Deshpande LM, Mathai D, et al. Early dissemination of NDM-1-and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother 2011; 55:1274-1278.
18. Walsh TR, Toleman MA. The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response. J Antimicrob Chemother 2011; 67:1-3.
19. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011; 11:355-362.
20. Leverstein-Van Hall MA, Stuart JC, Voets GM, et al. Global spread of New Delhi metallo-beta-lactamase 1. Lancet Infect Dis 2010; 10:830-831.
21. Savard P, Gopinath R, Zhu W, et al. First NDM-positive Salmonella sp. strain identified in the United States. Antimicrob Agents Chemother 2011; 55:5957-5958.
22. Lascols C, Hackel M, Marshall SH, et al. Increasing prevalence and dissemination of NDM-1 metallo-beta-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother 2011; 66:1992-1997.
23. Calbo E, Freixas N, Xercavins M, et al. Foodborne nosocomial outbreak of SHV1 and CTX-M-15-producing Klebsiella pneumoniae: epidemiology and control. Clin Infect Dis 2011; 52:743-749.
24. Overdevest I, Willemsen I, Rijnsburger M, et al. Extended-spectrum betalactamase genes of Escherichia coli in chicken meat and humans. The Netherlands. Emerg Infect Dis 2011; 17:1216-1222.
25. Luvsansharav UO, Hirai I, Niki M, et al. Prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae among healthy adult people in Japan. J Infect Chemother 2011; 17:722-725.
26. Abdul Rahman EM, El-Sherif RH. High rates of intestinal colonization with extended-spectrum lactamase-producing Enterobacteriaceae among healthy individuals. J Invest Med 2011; 59:1284-1286.
27. Perry JD, Naqvi SH, Mirza IA, et al. Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J Antimicrob Chemother 2011; 66:2288-2294.
28. Hoenigl M, Valentin T, Zarfel G, et al. Nosocomial Outbreak of Klebsiella pneumoniae carbapenemase producing Klebsiella oxytoca, Austria. Antimicrob Agents Chemother 2012; 56:2158-2161.
29. Won SY, Munoz-Price LS, Lolans K, et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011; 53:532-540.
30. Gaibani P, Ambretti S, Berlingeri A, et al. Outbreak of NDM-1-producing Enterobacteriaceae in northern Italy, July to August 2011. Euro Surveill 2011; 16:20027.
31. Kim MN, Yong D, An D, et al. Nosocomial clustering of NDM-1-producing Klebsiella pneumoniae sequence type 340 in four patients at a Korean tertiary care hospital. J Clin Microbiol 2012; 50:1433-1436.
32. Poirel L, Herve V, Hombrouck-Alet C, Nordmann P. Long-term carriage of NDM-1-producing Escherichia coli. J Antimicrob Chemother 2011; 66: 2185-2186.
33. Fuursted K, Scholer L, Hansen F, et al. Virulence of a Klebsiella pneumoniae strain carrying the New Delhi metallo-beta-lactamase-1 (NDM-1). Microbes Infect 2012; 14:155-158.
34. Lye DC, Earnest A, Ling ML, et al. The impact of multidrug resistance in healthcare-associated and nosocomial Gram-negative bacteraemia on mortality and length of stay: cohort study. Clin Microbiol Infect 2012; 18:502-508.
35. Kollef MH, Golan Y, Micek ST, et al. Appraising contemporary strategies to combat multidrug resistant Gram-negative bacterial infections: proceedings and data from the Gram-Negative Resistance Summit. Clin Infect Dis 2011; 53 (Suppl 2):S33-S55.
36. Miyakis S, Pefanis A, Tsakris A. The challenges of antimicrobial drug resistance in Greece. Clin Infect Dis 2011; 53:177-184.
37. Choi JP, Cho EH, Lee SJ, et al. Influx of multidrug resistant, Gram-negative bacteria (MDRGNB) in a public hospital among elderly patients from longterm care facilities: a single-center pilot study. Arch Gerontol Geriatr 2011; 54:e19-e22.
38. Marchaim D, Chopra T, Bogan C, et al. The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in longterm acute care facilities. Am J Infect Control 2012 [Epub ahead of print].
39. Wernli D, Haustein T, Conly J, et al. The application of the international health regulations to the global threat of antimicrobial resistance. PLoS Med 2011; 4:1-6.